News FocusGenetics

Hopping to a Better Protein

+ See all authors and affiliations

Science  05 Dec 2008:
Vol. 322, Issue 5907, pp. 1454-1455
DOI: 10.1126/science.322.5907.1454

You are currently viewing the summary.

View Full Text


Clinical trials are under way to test an innovative use of antisense technology to stem paralysis in Duchenne muscular dystrophy.